| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/15/2008 | US7399463 HSA-free formulations of interferon-beta |
| 07/15/2008 | CA2373296C Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders |
| 07/15/2008 | CA2207103C Methods to identify hemochromatosis |
| 07/15/2008 | CA2155711C Preventive or alleviating agent for medical symptoms caused by delayed allergy reactions |
| 07/15/2008 | CA2113023C Tnf receptor promoter |
| 07/10/2008 | WO2008083160A2 Methods and compositions for therapeutic treatment |
| 07/10/2008 | WO2008082323A1 Growth stimulating and cell regenerating composition and a method for the production thereof. |
| 07/10/2008 | WO2008081928A1 Pyrazolopyrimidine compound |
| 07/10/2008 | WO2008081581A1 Foxp3 peptide vaccine |
| 07/10/2008 | WO2008081111A1 OLIGO-β(1→3)-GLUCANES HAVING AN ALLERGIC-REACTION INHIBITING EFFECT AND APPLICATIONS THEREOF |
| 07/10/2008 | WO2008080461A1 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazo[4,5-b]pyridin-2-one derivatives useful as a2b adenosine receptor antagonists |
| 07/10/2008 | WO2008080218A1 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof |
| 07/10/2008 | WO2008080195A1 Compositions and methods for treating or preventing unwanted immune responses |
| 07/10/2008 | WO2008056266A3 Substituted 8-piperidinyl-2-pyridinyl-pyrimido [1,2-a]pyrimidin-6-one and 8-piperidinyl-2-pyrimidinyl-pyrimido[1,2-a]pyrimidin-6-one derivatives |
| 07/10/2008 | WO2008053444A3 Treating a respiratory condition with bifidobacterium |
| 07/10/2008 | WO2008036652A3 Amidines as modulators of indoleamine 2,3-dioxygenase |
| 07/10/2008 | WO2008005267A3 Sugar-free storage-stable antihistaminic syrups |
| 07/10/2008 | WO2002072778A3 Method for identifying inhibitors of g protein coupled receptor signaling |
| 07/10/2008 | US20080167471 comprising 4-[4-[4-(Hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]- alpha , alpha -dimethylbenzeneacetic acid hydrochloride; antiallergic agents and bronchodilators |
| 07/10/2008 | US20080167469 Preparing anhydrous 4-(4-(4-(Hydroxydiphenylmethyl)-1-piperidinyl)-1-hydroxybutyl)-alpha,alpha -dimethylbenzene acetic acid hydrochloride by azeotropic distillation of the corresponding hydrate |
| 07/10/2008 | US20080167457 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 07/10/2008 | US20080167362 Time-release tablets or capsules also containing an opoid or analgesic; cyclooxygenase-2 inhibitors |
| 07/10/2008 | US20080167345 Amide substituted indazoles as poly(ADP-ribose)polymerase(PARP) inhibitors |
| 07/10/2008 | US20080167318 Pharmaceutically active pyrrolidine derivatives |
| 07/10/2008 | US20080167289 Pyrimidinohydrodiazepinones, e.g., 2-(1,6-dihydro-4-methyl-6-oxopyridin-3-ylamino)-9-cyclopentyl-8,9-dihydro-5,7,7-trimethyl-5H-pyrimido[4,5-b][1,4]diazepin-6(7H)-one; especially c-Met kinase inhibitors; anticancer agents |
| 07/10/2008 | US20080167288 Substituted cyclic hydroxamates as lnhibitors of matrix metalloproteinases |
| 07/10/2008 | US20080167287 Imidazotriazines and imidazopyrimidines as kinase inhibitors |
| 07/10/2008 | US20080167249 Protective factors against inflammation, burns and noxious stimuli |
| 07/10/2008 | US20080167247 modulator of PKC V5 isozyme-specific peptide, or a modification, derivation, fragment, combination, or hybrid thereof; treatment of pain, cancer |
| 07/10/2008 | US20080167242 Toll-like receptor agonists and antagonists and methods of use thereof |
| 07/10/2008 | US20080167241 Mu-1, member of the cytokine receptor family |
| 07/10/2008 | US20080167234 Polypeptide does not contain a vertebrate high mobility group box protein (hmgb), that inhibit the release of a proinflammatory cytokine; treating inflammatory disease, autoimmune disease with monoclonal antibody or antigen-binding fragment |
| 07/10/2008 | US20080167228 Screening assay for the identification of inhibitors of macrophage migration inhibitory factor |
| 07/10/2008 | US20080166768 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof |
| 07/10/2008 | US20080166730 Therapeutic and diagnostic proteins comprising a SOCS box |
| 07/10/2008 | US20080166435 Composition and methods of use of an immunomodulator |
| 07/10/2008 | US20080166400 Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 07/10/2008 | US20080166368 Using microbiocidal peptides to enhance uptake of cytokines, polylysines, polyarginine and/or aluminum hydroxide in antigen presenting cells; stimulating host protection from invading pathogens |
| 07/10/2008 | US20080166366 Intracellular Delivery Vehicles |
| 07/10/2008 | US20080166363 Improved targetting |
| 07/10/2008 | US20080166360 Recombinant pollen protein for use in diagnosis, prevention and treatment of allergies |
| 07/10/2008 | US20080166358 Quinazoline derivatives and methods of treatment |
| 07/10/2008 | US20080166353 Using immunoglobulin specific to receptor for OX-2 membrane glycoprotein as diagnostic and therapeutic tool for treatment and prevention of asthma, infection, allergies, skin and cell proliferative disorders |
| 07/10/2008 | US20080166352 B7 related protein-1specific immunogobulin for use in treatment and prevention of asthma, skin, rheumatic and autoimmune disorders |
| 07/10/2008 | US20080166348 Pneumococcal vaccine and tumor necrosis factor antibodies; c-reactive protein |
| 07/10/2008 | US20080166339 Inhibition of osteopontin for treatment of relapsing autoimmune disease |
| 07/10/2008 | US20080166336 CD137 agonists to treat patients with IgE-mediated conditions |
| 07/10/2008 | US20080166331 Lactobacillus mixture comprising secreted cytokines for use in treatment and prevention of allergies |
| 07/10/2008 | US20080166325 Method of extensive culture of antigen-specific cytotoxic T cells |
| 07/10/2008 | US20080166321 Method for Identification of Virulence Determinants |
| 07/10/2008 | US20080166318 Methods and therapeutic combinations for the treatment of demyelination |
| 07/10/2008 | US20080166306 Administering a grape cell line culture; anti-inflammatory |
| 07/10/2008 | DE102007001370A1 RNA-kodierte Antikörper RNA-encoded antibody |
| 07/10/2008 | CA2674365A1 Foxp3 peptide vaccine |
| 07/10/2008 | CA2673965A1 Pyrazolopyrimidine compound |
| 07/10/2008 | CA2673870A1 Compositions and methods for the treatment of infections and tumors |
| 07/10/2008 | CA2673752A1 Compositions and methods for stimulating an immune response |
| 07/10/2008 | CA2673668A1 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof |
| 07/10/2008 | CA2673659A1 Methods of detecting and diagnosing inflamatory responses and disorders by determining the level of soluble b7-h4 |
| 07/09/2008 | EP1942191A1 Nucleic acid construct containing full-length genome of human hepatitis C virus, recombinant full-length virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus particle |
| 07/09/2008 | EP1942190A2 Immoglobulin fusion proteins having modified effector functions and uses thereof |
| 07/09/2008 | EP1942187A1 Cytokine protein family |
| 07/09/2008 | EP1942114A2 Mammalian cytokines; related reagents and methods |
| 07/09/2008 | EP1942108A1 Compound containing basic group and use thereof |
| 07/09/2008 | EP1941904A2 Anti-TNF antibodies and methotrexate in the treatment of autoimmune diseases |
| 07/09/2008 | EP1941892A2 Anti-allergy lactic acid bacteria |
| 07/09/2008 | EP1941872A1 Use of TNF-alpha inhibitors for treating nerve root injury |
| 07/09/2008 | EP1940870A2 Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target |
| 07/09/2008 | EP1940777A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
| 07/09/2008 | EP1940465A2 Novel use of il-1beta compounds |
| 07/09/2008 | EP1940464A1 Hexosylceramides as adjuvants and their uses in pharmaceutical compositions |
| 07/09/2008 | EP1940458A1 Compositions for and methods of granzyme b inhibition |
| 07/09/2008 | EP1940430A2 Listeria-induced immunorecruitment and activation, and methods of use thereof |
| 07/09/2008 | EP1940418A1 Sulfatides for treatment of autoimmune disorders |
| 07/09/2008 | EP1940415A1 19,23,24,25,26,27-hexanor-1alpha-hydroxyvitamin d3 |
| 07/09/2008 | EP1940388A2 Dpp iv inhibtor for use in the treatment of autoimmune diseases and graft rejection |
| 07/09/2008 | EP1694320B1 Use of compositions comprising oleanic acid and ursolic acid for the preparation of a medicament for the treatment of hypersensitivity and hyperreactivity |
| 07/09/2008 | EP1465863B1 Potassium channel modulators |
| 07/09/2008 | EP1448211B1 A composition for lowering the concentration of intestinal pathogenic peptides |
| 07/09/2008 | EP1404362B1 Signal-1/signal-2 bifunctional peptide inhibitors |
| 07/09/2008 | EP1303490B1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 07/09/2008 | EP1276729B1 New neurokinin antagonists for use as medicaments |
| 07/09/2008 | EP1156820B1 Use of vascular endothelial growth factor-2 (vegf-2) |
| 07/09/2008 | CN101218340A Polysaccharide produced by microorganism belonging to genus bifidobacterium |
| 07/09/2008 | CN101218256A Antibodies against cd38 for treatment of multiple myeloma |
| 07/09/2008 | CN101218254A Interleukin-17F antibodies and other IL-17F signaling antagonists and uses therefor |
| 07/09/2008 | CN101217953A Compounds having immunomodulator activity |
| 07/09/2008 | CN101217948A Percutaneously absorptive ophthalmic preparation comprising epinastine |
| 07/09/2008 | CN101215601A Effectors of innate immunity determination |
| 07/09/2008 | CN101215544A Inflammation-inhibiting compounds |
| 07/09/2008 | CN101214372A Construction method of protein vaccine for in vivo inducing autoantibody aiming at TNF-alpha molecule |
| 07/09/2008 | CN101214345A Chinese medicine preparation for treating various itching skin diseases such as eczema dermatitis, urticaria and etc. |
| 07/09/2008 | CN101214307A Chinese medicine powder medicine for treating eczema especially ear eczema |
| 07/09/2008 | CN101214270A Acanthopanax senticosus effective fraction extract, preparation and application thereof |
| 07/09/2008 | CN101214265A Chinese cephalosporin cordyceps sinensis mixed powder and preparation method |
| 07/09/2008 | CN101214224A Recombination human interferon injection |
| 07/09/2008 | CN100400659C Component of bromelain |
| 07/09/2008 | CN100400546C Cell surface molecule mediating cell adhesion and signal transmission |
| 07/09/2008 | CN100400513C Phenylalanine enamide derivatives |
| 07/09/2008 | CN100400511C Cathepsin S inhibitors |